文献速递神经肿瘤

老年颅咽管瘤患者内镜下经鼻手术的临床特征与治疗结局

Clinical characteristics and therapeutic outcomes after endoscopic endonasal surgery for craniopharyngioma in the elderly.
PubMed 文献 · J Neurosurg · 2024-09-20

这项回顾性队列研究纳入2013至2022年接受内镜下经鼻手术的193例颅咽管瘤患者,比较非老年组(18-64岁,161例)与老年组(≥65岁,32例)的临床特征与结局。老年组术前记忆障碍、乏力、垂体功能减退和脑积水比例更高,术后肺炎更多,但两组全切除率、围手术期死亡率和严重下丘脑功能障碍无显著差异。作者认为,经适当围手术期管理,内镜下经鼻手术是老年颅咽管瘤患者可行的治疗选择。

要点

  • 老年组术前记忆障碍(18.8% vs 4.3%)、乏力(34.4% vs 9.3%)、垂体功能减退(90.6% vs 68.7%)和脑积水(40.6% vs 18%)比例均高于非老年组。
  • 老年组术后肺炎发生率高于非老年组(21.9% vs 5%,p=0.004),但全切除率、围手术期死亡率和严重下丘脑功能障碍两组无显著差异。
  • 多因素Cox回归显示,肿瘤钙化(HR 3.406)和术前脑积水(HR 3.688)与生存期缩短独立相关。

核心结论

  • 本研究表明,内镜下经鼻手术是老年颅咽管瘤患者可行的治疗选择;经适当围手术期管理,该手术不显著增加死亡率,在选定人群中耐受良好。

研究设计与样本

  • 回顾性队列研究,纳入2013至2022年接受内镜下经鼻手术的年龄≥18岁颅咽管瘤患者。
  • 按年龄分为非老年组(18-64岁)和老年组(≥65岁),比较患者与肿瘤特征、手术结局、并发症和随访情况。
  • 共193例患者符合纳入标准,非老年组161例(83.4%),老年组32例(16.6%)。

主要发现

  • 术前老年组较非老年组更常见记忆障碍(18.8% vs 4.3%,p=0.010)、乏力或精力下降(34.4% vs 9.3%,p=0.001)、垂体功能减退(90.6% vs 68.7%,p=0.012)和脑积水(40.6% vs 18%,p=0.005),更常无症状(9.4% vs 1.2%,p=0.033),头痛更少(31.3% vs 57.8%,p=0.006)。
  • 老年组症状持续时间更长(中位数[IQR] 9.5[13]个月 vs 5[10]个月,p=0.001),合并症评分更高(p<0.001)。
  • 术后非老年组和老年组全切除分别为145例(90.1%)和28例(87.5%),老年组肺炎更多(21.9% vs 5%,p=0.004)。
  • 两组切除范围(p=0.541)、病理亚型(造釉细胞型88.2% vs 75.0%,p=0.089)、手术时间(均值±标准差307.8±68.3分钟 vs 323.5±86.0分钟,p=0.257)、估计出血量(中位数[IQR] 300[200] ml vs 300[238] ml,p=0.594)、住院时间(中位数[IQR] 15[8]天 vs 15[22]天,p=0.964)、围手术期死亡率(2.5% vs 3.1%,p>0.99)和术后严重下丘脑功能障碍(37.9% vs 50.0%,p=0.237)均无显著差异。
  • 多因素Cox回归显示,肿瘤钙化(HR 3.406,95%CI 1.859-27.233,p=0.038)和术前脑积水(HR 3.688,95%CI 1.310-10.386,p=0.013)与生存期缩短独立相关;老年组中位随访时间更短(44个月 vs 71个月,p=0.001),复发率为0%(vs 7.1%,p=0.132)。

临床怎么用

  • 作者认为,经适当围手术期管理,内镜下经鼻手术是老年颅咽管瘤患者可行的治疗选择,不显著增加死亡率,在选定人群中耐受良好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Craniopharyngiomas (CPs) in adults are rare benign epithelial tumors, and few contemporary studies have explored outcomes after surgical treatment in elderly patients, especially with regard to endoscopic endonasal surgery (EES). METHODS: A retrospective cohort study was conducted on patients aged ≥ 18 years with CP who were treated with EES from 2013 to 2022. The cohort was divided into nonelderly (18-64 years) and elderly (≥ 65 years) groups based on age. Various parameters, including patient and tumor characteristics, surgical outcomes, complications, and follow-up, were compared between the two age groups. RESULTS: A total of 193 patients met the inclusion criteria, with 161 (83.4%) patients in the nonelderly group and 32 (16.6%) patients in the elderly group. Preoperatively, older patients were more likely to have memory impairment (4.3% vs 18.8%, p = 0.010), fatigue or decreased energy (9.3% vs 34.4%, p = 0.001), hypopituitarism (68.7% vs 90.6%, p = 0.012), or hydrocephalus (18% vs 40.6%, p = 0.005), and they were more likely asymptomatic (1.2% vs 9.4%, p = 0.033) and less likely to experience headache (57.8% vs 31.3%, p = 0.006). Patients in the elderly group had a longer symptom duration (median [IQR] 5 [10] months vs 9.5 [13] months, p = 0.001) and higher comorbidity scores (p < 0.001). Postoperatively, gross-total resection was achieved in 145 (90.1%) and 28 (87.5%) patients in the nonelderly and elderly groups, respectively. Older patients were more likely to develop pneumonia (5% vs 21.9%, p = 0.004). There were no significant differences in the extent of resection (p = 0.541), pathological subtypes (88.2% vs 75.0% adamantinomatous, p = 0.089), operation time (mean ± SD 307.8 ± 68.3 minutes vs 323.5 ± 86.0 minutes, p = 0.257), estimated blood loss (median [IQR] 300 [200] ml vs 300 [238] ml, p = 0.594), length of stay (median [IQR] 15 [8] days vs 15 [22] days, p = 0.964), perioperative mortality (2.5% vs 3.1%, p > 0.99), or postoperative severe hypothalamic dysfunction (37.9% vs 50.0%, p = 0.237) between the groups. Multivariate Cox regression analysis demonstrated that tumor calcification (HR 3.406, 95% CI 1.859-27.233, p = 0.038) and preoperative hydrocephalus (HR 3.688, 95% CI 1.310-10.386, p = 0.013) were independently associated with decreased survival. The median follow-up period in the elderly group was shorter (71 months vs 44 months, p = 0.001), and no recurrence was observed (7.1% vs 0%, p = 0.132). CONCLUSIONS: This study demonstrates that EES is a viable treatment option for older CP patients. With appropriate perioperative management, EES does not significantly increase mortality and, in selected populations, is well tolerated by patients.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bao YY, Pan LS, Cao Y, et al. Clinical characteristics and therapeutic outcomes after endoscopic endonasal surgery for craniopharyngioma in the elderly. J Neurosurg. 2024. PMID: 39303301. doi:10.3171/2024.5.JNS232533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。